EE693 Cost-Effectiveness of Atidarsagene Autotemcel (ARSA-CEL) Gene Therapy for Treating Metachromatic Leukodystrophy (MLD) in Ireland, Belgium, and the Netherlands As a Part of the Beneluxa Initiative
Abstract
Authors
A Olaye K Bean R Velikanova S Wolters B Miller I Jensen F Pang